FibroGen Inc
LSE:0IL8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
FibroGen Inc
LSE:0IL8
|
US |
|
Societe de Services de Participations, de Direction et d'Elaboration SA
LSE:0OH1
|
BE |
|
A
|
Abbvie Inc
XETRA:4AB
|
US |
|
Discovery Ltd
F:D3H
|
ZA |
|
M
|
Mitsubishi Electric Corp
DUS:MIE1
|
JP |
|
Springer Nature AG & Co KgaA
XETRA:SPG
|
DE |
|
E
|
El Pollo Loco Holdings Inc
F:EP6
|
US |
|
Rivian Automotive Inc
NASDAQ:RIVN
|
US |
|
Synaptics Inc
NASDAQ:SYNA
|
US |
|
A
|
Aegean Airlines SA
SWB:32A
|
GR |
Wall St Price Targets
0IL8 Price Targets Summary
FibroGen Inc
According to Wall Street analysts, the average 1-year price target for
0IL8 is 44.3874 USD with a low forecast of 43.9523 USD and a high forecast of 45.693 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0IL8's stock price target?
Price Target
44.3874
USD
According to Wall Street analysts, the average 1-year price target for
0IL8 is 44.3874 USD with a low forecast of 43.9523 USD and a high forecast of 45.693 USD.
What is the Revenue forecast for FibroGen Inc?
Projected CAGR
-32%
Over the last 11 years, the compound annual growth rate for Revenue has been -11%. The projected CAGR for the next 4 years is -32%.